Evidence map›Paper›PMID 36314476›Full record

ArticleJournal of the International Association of Providers of AIDS Care

Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate.

Angsana Phuphuakrat, Ekawat Pasomsub, Wasun Chantratita, Surakameth Mahasirimongkol, Sinee Disthabanchong, Somnuek Sungkanuparph, Sasisopin Kiertiburanakul

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the International Association of Providers of AIDS Care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Angsana PhuphuakratDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.ORCID 0000-0003-2474-1850
Ekawat PasomsubDepartment of Pathology, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.
Wasun ChantratitaCenter for Medical Genomics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Surakameth MahasirimongkolDivision of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
Sinee DisthabanchongDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.
Somnuek SungkanuparphChakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
Sasisopin KiertiburanakulDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.ORCID 0000-0003-4379-4704
Ramathibodi Hospital · THMahidol University · THMinistry of Public Health · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tenofovir disoproxil fumarate (TDF) associates with renal tubular dysfunction (RTD) in some people living with HIV (PLWH). We studied clinical and genetic factors associated with RTD in Thai PLWH receiving TDF. RTD was diagnosed in 13 of 65 (20%) patients. The median (interquartile range) age and CD4 cell counts were 43.8 (40.4-50.9) years and 554 (437-716) cells/mm

Indexed as

Anti-HIV AgentsHIV InfectionsHumansRisk FactorsTenofovirThailandAnti-HIV AgentsTenofovirHIVpharmacogenomicsrenal tubular dysfunctionrisk factorstenofovir disoproxil fumarate

Identifiers

PMID36314476
PMCPMC9623366
OpenAlexW4308189804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.